Back
Pacific Biosciences of California Vs. Bowman Consulting Group Industry Stock Comparison
Buy
52
PACB
Pacific Biosciences of California
Last Price:
1.68
Seasonality Move:
2.7%
Sell
35
BWMN
Bowman Consulting Group
Last Price:
32.24
Seasonality Move:
-0.83%
Buy
52
Pacific Biosciences of California (PACB)
is a Buy
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.68. The Score for PACB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.08. The Score for BWMN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.08
The current trend is relatively stagnant and BWMN is experiencing selling pressure, which indicates risk of future bearish movement.
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 34.29 | Sell |
Chaikin Money Flow: | -5907300 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.32 - 2.96) | Sell |
Bollinger Bands (100): | (2.7 - 7.9) | Sell |
BWMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 48.68 | Sell |
Chaikin Money Flow: | -87106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.61 - 32.65) | Buy |
Bollinger Bands (100): | (30.83 - 36.55) | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.76 | Sell |
20-day SMA: | 1.82 | Sell |
50-day SMA: | 3.13 | Sell |
200-day SMA: | 7.28 | Sell |
8-day EMA: | 1.76 | Sell |
20-day EMA: | 2.02 | Sell |
50-day EMA: | 3.12 | Sell |
200-day EMA: | 6.47 | Sell |
BWMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.81 | Buy |
20-day SMA: | 31.4 | Buy |
50-day SMA: | 34.08 | Sell |
200-day SMA: | 31.55 | Buy |
8-day EMA: | 31.82 | Buy |
20-day EMA: | 32.06 | Buy |
50-day EMA: | 33.01 | Sell |
200-day EMA: | 31.59 | Buy |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.34 per share.
Pacific Biosciences of California Technical Analysis
Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bowman Consulting Group Technical Analysis
Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |